Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -4.76x is 92% above its 5-year average of -63.40x, near the high end of its 5-year range (-188.54x–-4.76x).
As of the fiscal period ended Saturday, December 31, 2022.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2022 (2022-12-31): -4.76x.
INTEREST COVERAGE RATIO
-4.76x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
-63.40x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
+92.49%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+25.33%
vs the sector median at left
MetaVia Inc.
Market Cap
$9.62M
Interest Coverage Ratio
-4.76x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
-63.40x
Market Cap
$9.82M
Interest Coverage Ratio
-54.10x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.10M
Interest Coverage Ratio
-129.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.66M
Interest Coverage Ratio
-12.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.18M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.30M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.39M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MetaVia Inc. (MTVA) | $9.62M | -4.76x | N/A | N/A | -63.40x |
| Valion Bio, Inc. (VBIO)vs › | $9.82M | -54.10x | N/A | N/A | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.10M | -57.26x | N/A | N/A | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.10M | -129.91x | N/A | N/A | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.66M | -12.65x | N/A | N/A | N/A |
| Ainos, Inc. (AIMD)vs › | $9.65M | -19.65x | N/A | N/A | N/A |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.18M | N/A | N/A | N/A | N/A |
| Senti Biosciences, Inc. (SNTI)vs › | $10.30M | N/A | N/A | N/A | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $10.39M | N/A | N/A | N/A | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.41M | -219.72x | N/A | N/A | N/A |
Interest Coverage
-4.8x
Debt/Equity
0.03
Current Ratio
2.06
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2022-12-31 | -4.76x |
| 2019-06-30 | -134.79x |
| 2019-03-31 | -188.54x |
| 2018-12-31 | -18.54x |
| 2018-09-30 | -34.34x |
| 2018-06-30 | -45.38x |
| 2018-03-31 | -44.15x |
| 2017-12-31 | -36.69x |
| 2017-09-30 | -64.69x |
| 2016-09-30 | -7.16x |
| 2015-09-30 | -11.32x |
| 2015-03-31 | -2.30x |
